Inactive Instrument

Company Ekso Bionics Holdings Inc OTC Bulletin Board

Equities

EKSO

US2826442020

Advanced Medical Equipment & Technology

Business Summary

Ekso Bionics Holdings, Inc. designs, develops, and markets exoskeleton products. Its exoskeleton technology serves multiple markets and can be utilized both by able-bodied persons and persons with physical disabilities or impairments. Its products include EksoNR, which is a wearable robotic exoskeleton specifically designed to be used in a rehabilitation setting; Ekso Indego Therapy is a modular, adjustable, lightweight, lower-limb powered exoskeleton; Ekso Indego Personal is a lightweight powered lower limb orthosis; Ekso Nomad is a power Knee Ankle Foot Orthosis, and Ekso EVO is a wearable upper body exoskeleton. The Company enables individuals with neurological conditions affecting gait, including acquired brain injury (ABI) and spinal cord injury (SCI), to rehabilitate and to walk again; assist individuals with a range of upper extremity impairments and allow industrial workers to perform difficult repetitive work for extended periods. Its segments include EksoHealth and EksoWorks.

Sales per Business

USD in Million2022Weight2023Weight Delta
EksoHealth
96.8 %
12 91.6 % 18 96.8 % +49.64%
EksoWorks
3.2 %
1 8.4 % 1 3.2 % -46.67%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
68.4 %
7 50.8 % 13 68.4 % +90.64%
Other EMEA
10.3 %
3 22.0 % 2 10.3 % -33.86%
APAC
8.3 %
2 17.5 % 2 8.3 % -32.61%
Poland
7.7 %
-- 1 7.7 % -
Other Americas
2.7 %
0 2.0 % 0 2.7 % +96.43%
Germany
2.6 %
1 7.8 % 0 2.6 % -52.50%

Managers

Managers TitleAgeSince
Chief Executive Officer 54 21-03-31
Director of Finance/CFO 50 17-04-30
Chief Operating Officer 52 -
Investor Relations Contact - -
Human Resources Officer - 22-03-31
Corporate Officer/Principal - 21-12-31
Corporate Officer/Principal - 19-12-31
Sales & Marketing - 19-08-31
Sales & Marketing - -
Corporate Officer/Principal - -

Members of the board

Members of the board TitleAgeSince
Director/Board Member 56 21-12-24
Director/Board Member 69 20-12-28
Director/Board Member 39 18-03-10
Chief Executive Officer 54 21-03-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 18,174,426 16,500,566 ( 90.79 %) 0 90.79 %

Shareholders

NameEquities%Valuation
Kent Lake Capital LLC
3.293 %
596,050 3.293 % 628 833 $
Vanguard Group, Inc. (Subfiler)
3.156 %
571,155 3.156 % 602 569 $
364,913 2.016 % 384 983 $
Azimut Capital Management SGR SpA
1.155 %
209,119 1.155 % 220 621 $
147,990 0.8177 % 156 129 $
Kecheng Li
0.8095 %
146,521 0.8095 % 154 580 $
Mary Cloyd
0.7862 %
142,288 0.7862 % 150 114 $
Geode Capital Management LLC
0.6097 %
110,349 0.6097 % 116 418 $
Scott Davis
0.5742 %
103,934 0.5742 % 109 650 $
Charles Li
0.5164 %
93,463 0.5164 % 98 603 $

Company contact information

Ekso Bionics Holdings, Inc.

101 Glacier Point Suite A

94901, San Rafael

+510 984 1761

http://www.eksobionics.com
address Ekso Bionics Holdings Inc(EKSO)
  1. Stock Market
  2. Equities
  3. EKSO Stock
  4. EKSO Stock
  5. Company Ekso Bionics Holdings Inc